Researches and develops robotic technologies, primarily the Hybrid Assistive Limb (HAL). Produces and sells HAL devices for medical, welfare, and industrial applications. Now — the numbers.
This is an established company with proven profits.
Average growth of 17% a year over the last 4 years. Red columns mark years that ended in a loss.
If every debt were paid off today, $53.7M would still be left in the vault — a solid cushion for hard times.
The market pays 241.6× for every dollar this company earns in a year — a price that already assumes things go well.
No analyst target is on record for this company.
An investor who bought at the very peak is down 62% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
Over the last 4 years, sales grew about 17% a year on average.
There is $58.8M in the vault; even if every debt were paid off, $53.7M would remain.
The company’s market value is 242 times its annual profit. Even a small disappointment could hit the price hard.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
One-line summary: few numbers, an untested story. Keep watching.
Not covered, because the filings we hold do not carry it: earnings execution, the revenue breakdown.